(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) fell by a staggering 26.52% in 10 sessions from €11.84 to €8.70 at 07:39 EST on Thursday, after five successive sessions in a row of losses. CAC 40 is jumping 0.26% to €7,131.12, after three sequential sessions in a row of gains.
About ABL Diagnostics
ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
More news about ABL Diagnostics (ABLD.PA).
